SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Essential Therapeutics (ETRX) formerly Microcide (MCDE
An SI Board Since January 1998
Posts SubjectMarks Bans Symbol
415 15 0 ETRX
Emcee:  John O'Neill Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
290rockrat asked me to take a look at the abstracts. They're an impressive arraDr. John M. de Castro-8/22/2000
289No, I'm not in the industry. Just heard Rick's call to arms (call to misim1-8/20/2000
288Gang, FWIW, Dr. Miller, head of R&D, upped his stake some 80% this spring atuck-8/19/2000
287chuckle (eom)scaram(o)uche-8/19/2000
286S. SILEN & T. ROCKRAT Silicon Investor Bile-ogical Association (SIBIA), Somtuck-8/19/2000
285Thanks for the info....perhaps you work in the industry?? I find the articles oJohn O'Neill-8/19/2000
284Stuart.... one BIG thank you! (eom)scaram(o)uche-8/19/2000
283In Vitro Activity of Aztreonam, Fosfomycin, Gentamicin or Levofloxacin against scaram(o)uche-8/19/2000
282RWJ-333441 (MC-04,546), a New Cephalosporin with High Affinity for PBP 2a and Stsim1-8/19/2000
281MexXY Efflux Pump is Required for Antagonism of Aminoglycosides by Divalent Catisim1-8/19/2000
280MF-EA371-a and MF-EA371-D, Novel Bacterial Efflux Pump Inhibitors from Microbialsim1-8/19/2000
279Regulated Bacterial Gene Expression during Host Infection J. P. ZHANG, T. CHRISsim1-8/19/2000
278Mini-lecture - Pharmacodynamics of Antimicrobials in Humans M. N. DUDLEY Microcsim1-8/19/2000
277Pharmacokinetics of a Novel Cephalosporin RWJ-333441 (MC-04,546) and Its L-Asparsim1-8/19/2000
276More Inhibitors of Fungal Efflux Pumps A. MISTRY1, M. S. WARREN1, J. BLAIS1, A.sim1-8/19/2000
275Bactericidal Activity and Postantibiotic Effects of the Novel Cephalosporins RWJsim1-8/19/2000
274In Vitro Inhibitory Activity of the New Cephalosporin RWJ-333441 (MC-04,546) Agasim1-8/19/2000
273Mutations in the cdr1 Gene of Candida Albicans Encoding MDR Efflux Pump May Resusim1-8/19/2000
272An Inhibitor of the Mex Pumps from Pseudomonas aeruginosa is also a Substrate ofsim1-8/19/2000
271An Efflux Pump Inhibitor (EPI), MC-04,124, Enhances the Activity of Macrolides asim1-8/19/2000
270Preparative-Scale Production of UDP-MurNAc-Pentapeptide for High-throughput Scresim1-8/19/2000
269Addressing the Stability of C-Capped Dipeptide Efflux Pump Inhibitors that Potensim1-8/19/2000
268Can Existing b-lactams be Improved Upon? M. N. DUDLEY Microcide Pharmaceuticalssim1-8/19/2000
267Peptidomimetics of Dipeptide Amide Efflux Pump Inhibitors Potentiate the Activitsim1-8/19/2000
266Discovery of Novel Anti-MRSA Cephalosporin RWJ-333441 (MC-04,546). Relationshipssim1-8/19/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News